Clinical and Serological Studies on a Further Attenuated Live Measles Virus AIK Vaccine

Experimental study of a further attenuated live measles vaccine of the Sugiyama strain in Iran

Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine.

A new, further attenuated measles vaccine, developed by propagation of Edmonston B measles virus in the chorioallantoic membrane in ovo, has been clinically evaluated in children and found to compare favorably with a commercially available product. The vaccine is prepared in chick embryo tissue culture and appears to possess noteworthy stability at 4 C.

Development of an Attenuated Live Virus Vaccine against Sheep Pox

Serological Responses of Horses Immunized with Live Attenuated African Horse Sickness Vaccine

Erythema multiforme following live attenuated trivalent measles-mumps-rubella vaccine.